Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks.
Platelet hyperaggregability was tested in 62 TIA patients by means of the formalin fixing principle of Wu and Hoak. Compared to age-matched controls, the platelet aggregates ratio (PAR) was reduced from 0.99 +/- 0.04 SD to 0.807 +/- 0.14 SD. This means a highly significant increase of circulating platelet aggregates (CPA) in untreated TIA patients, regardless of the interval sinche the last attack (from 2 days to 1 year). PAR was especially reduced in patients with abnormal angiography (expressing pronounced cerebral or diffuse ATS) and it was possibly affected by previous antiplatelet treatment with ASA.
D001241:Aspirin / Q000627:therapeutic use*; D002533:Cerebral Angiography; D004176:Dipyridamole / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000097:blood; D002546:Ischemic Attack, Transient / Q000097:blood* / Q000517:prevention & control; D008875:Middle Aged; D010974:Platelet Aggregation
D004176:Dipyridamole; D001241:Aspirin